Mohammad Asadzadeh | Microbiology | Excellence in Research Award

Published on by Molecular Biologist

Dr. Mohammad Asadzadeh | Microbiology | Excellence in Research Award

Teaching Assistant | Kuwait University | Kuwait

Dr. Mohammad Asadullah Asadzadeh is an Iranian clinical microbiologist and academic based in Kuwait, specializing in medical and molecular mycology. His work bridges teaching, diagnostic laboratory practice, and research, with emphasis on Candida epidemiology, antifungal resistance, and molecular characterization of fungal pathogens relevant to the Middle East. He has contributed extensively to hospital and national reference laboratories, supporting public health microbiology and evidence-based diagnostics. His scholarly impact includes 50 scientific documents, 1,116 citations across 780 citing publications, and an h-index of 20, reflecting sustained contributions to clinical microbiology and translational fungal research.

Citation Metrics (Scopus)

1200

1000

800

600

400

200

0

Citations
1,116

Documents
50

h-index
20

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile View ORCID Author Profile

Featured Publications

Alaa Niamah | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Alaa Niamah | Microbiology | Best Researcher Award 

Professor of Microbiology | University of Basrah | Iraq

Prof. Dr. Alaa Kareem Niamah is a Professor of Dairy Microbiology at the University of Basrah, Iraq, recognized for his extensive research in food microbiology, probiotics, bacteriocins, and dairy biotechnology. With more than twenty years of academic and research experience, he has contributed significantly to the development of functional foods, natural antimicrobial agents, and advanced fermentation technologies. His scientific impact is reflected in 1,038 citations across 929 documents, supported by 47 published documents and an h-index of 17. Dr. Niamah’s work addresses microbial interactions, food safety, enzymatic activity, and the optimization of dairy and plant-based fermentation systems. He has collaborated with international institutions, supervised postgraduate research, and served on editorial boards, scientific committees, and conference panels in multiple countries. Through his interdisciplinary approach to microbial biotechnology and dairy science, he continues to advance innovative solutions for food quality, safety, and sustainable production.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Management of agri-food wastes via novel biotechnological methods: Emerging trends and technological advances. In Editor1, E. E. (Ed.)

 Applications of green synthesis of nanoparticles using microorganisms in food and dairy products: A review. Journal Name, Volume(Issue)

Immunomodulation capability and cytotoxicity activities of novel exopolysaccharides produced by a new local strain, Bifidobacterium longum subsp. infantis strain Iraq-Basrah 3. Journal of Applied Biology and Biotechnology, Volume(Issue),

Exploring the chemistry and sources of microbial 1,2-propanediol (propylene glycol) with a focus on biosynthesis, extraction, and identification for nutraceutical significance and human health. In Editor1, E. E. (Ed.)

Getachew Alamnie | Microbiology | Editorial Board Member

Published on by Molecular Biologist

Assist Prof Dr. Getachew Alamnie | Microbiology | Editorial Board Member 

Researcher | Mekdela Amba University | Ethiopia

Dr. Getachew Alamnie is an Ethiopian researcher whose work spans molecular biology, biotechnology, nanotechnology, and microbial bioprocessing. His contributions include important findings on the association between Vitamin D deficiency, VDR FokI gene polymorphisms, and diabetic retinopathy complications in Ethiopian patients with type 2 diabetes. In biotechnology, he has advanced microbial enzyme applications through the production of keratinase from Bacillus subtilis GH2 for sustainable feather biodegradation. Dr. Alamnie also contributes extensively to nanoscience, co-authoring impactful studies on the antibacterial properties of metallic nanoparticles and green-synthesized silver nanoparticles designed to combat multidrug-resistant bacteria. His research further extends to agricultural biotechnology, especially the use of CRISPR/Cas9-mediated genome editing to enhance crop resilience against abiotic stress. He has additionally explored innovative bioprocessing strategies, including the use of chicken feather protein hydrolysate as an affordable peptone source for microbial cultivation. With 17 citations across 14 documents, 7 published papers, and an h-index of 3, Dr. Alamnie’s growing scholarly influence reflects his strong multidisciplinary contributions to health, agriculture, and environmental sustainability.

Profiles: Scopus | ORCID

Featured Publications

Melake, A., Alamnie, G., & Mekonnen, M. Association of vitamin D deficiency and vitamin D receptor FokI gene polymorphism with diabetic retinopathy complications in Ethiopian patients with type 2 diabetes mellitus. International Journal of Immunogenetics.

Girma, A., Mebratie, G., Mekuye, B., Abera, B., Bekele, T., & Alamnie, G. Antibacterial capabilities of metallic nanoparticles and influencing factors. Nano Select.

Adane, M., & Alamnie, G. CRISPR/Cas9 mediated genome editing for crop improvement against abiotic stresses: Current trends and prospects. Functional & Integrative Genomics.

Alamnie, G. Production of keratinase enzyme from B. subtilis GH2 and its application in feather biodegradation. Biomass Conversion and Biorefinery.

Pramod Bhasme | Microbiology | Best Review Paper Award

Published on by Molecular Biologist

Dr. Pramod Bhasme | Microbiology | Best Review Paper Award 

McGowan Institute for Regenerative Medicine | India

Dr. Pramod Bhasme is a distinguished researcher specializing in microbiology, molecular biology, and regenerative medicine, with expertise in bacterial pathogenesis, biofilm regulation, and wound healing. He earned his B.Sc., M.Sc., and M.Phil. in Microbiology from Karnatak University Dharwad, India, where he studied bacteriocins and mastitis-related pathogens, before completing a Ph.D. in Microbiology at the University of Chinese Academy of Sciences, Beijing, under Prof. Ma Luyan. His doctoral research focused on quorum sensing, virulence regulation, and biofilm disruption in Pseudomonas aeruginosa. He later held a postdoctoral fellowship at Indiana University and currently serves as a Postdoctoral Associate at the McGowan Institute for Regenerative Medicine, University of Pittsburgh. His work explores electroceutical technologies, bacteriophage therapy, senescence biology, and wound-healing strategies using transgenic models. Dr. Bhasme’s research interests include quorum sensing inhibition, cyclic-di-GMP signaling, protein engineering, and macrophage–keratinocyte interactions, with a strong focus on translational medicine. A recipient of the CAS-TWAS President’s Fellowship, he has published in leading journals such as Nature Communications, ACS Nano, Environmental Microbiology, JoVE, and mLife. With 11 publications, 231 citations across 211 documents, and an h-index of 8, he is recognized as an emerging leader in infection biology and regenerative medicine.

Profile: Scopus | Google Scholar

Featured Publications

Sharma, A., Anthony, A. J., Gnyawali, S., Bhasme, P., et al. The mitochondrial bioenergetics of functional wound closure is dependent on macrophage to keratinocyte exosomal crosstalk. ACS Nano. (Accepted).

Zhang, Y., Bhasme, P., et al. Dual functions: A coumarin-chalcone conjugate inhibits cyclic-di-GMP and quorum sensing signaling. mLife, 2(3), 284–293.

El Masry, M., Bhasme, P., et al. Swine model of biofilm infection and invisible wound. Journal of Visualized Experiments, (196).

Pal, D., Ghatak, S., Bhasme, P., et al. Identification of a physiologic vasculogenic fibroblast state to achieve tissue repair. Nature Communications, 14(1), 1129.

Xu, A., Wang, D., Bhasme, P., et al. Mutations in WspA lock the Wsp signal system into an active state. Environmental Microbiology.

 

Kaixia Mi | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Kaixia Mi | Microbiology | Best Researcher Award 

Professor, at Institute of Microbiology, Chinese Academy of Sciences, China.

Dr. Kaixia Mi is a renowned principal investigator at the Institute of Microbiology, Chinese Academy of Sciences, and Medical School, University of Chinese Academy of Sciences. 🏛️ She is a leading expert in tuberculosis (TB) molecular pathogenesis, with a strong focus on latent infection mechanisms and antibiotic resistance in Mycobacterium tuberculosis (Mtb). 🧪 Dr. Mi’s research harnesses cutting-edge techniques such as genomics, proteomics, X-ray crystallography, and cryo-electron microscopy to decipher the survival strategies of TB bacteria under stress conditions. Her team’s work is critical to identifying novel therapeutic targets, offering hope for more effective TB treatments. 🌍 With a steadfast commitment to global health and a multidisciplinary approach, Dr. Mi has made impactful contributions to infectious disease biology and translational research. Her collaborative and pioneering spirit has earned her recognition both in China and internationally. 🥼

Professional Profile

Scopus

🎓 Education

Dr. Kaixia Mi completed her Ph.D. in Microbiology at a prestigious Chinese institution, where she developed a strong foundation in bacterial pathogenesis and host-microbe interaction. 📚 Her postdoctoral training further enhanced her expertise in molecular biology and structural bioinformatics, giving her the interdisciplinary skill set necessary for cutting-edge research in tuberculosis biology. 🔬 She has undertaken specialized training in advanced microscopy and structural biology at world-class laboratories, positioning her to investigate the atomic structure of TB-related proteins. Throughout her academic journey, Dr. Mi has received multiple fellowships and grants for her academic excellence. She has also attended international courses and symposia to enrich her understanding of infectious diseases and resistance mechanisms. 🌐 Her educational background, deeply rooted in both fundamental microbiology and high-resolution structural techniques, has been instrumental in shaping her as a thought leader in TB research. 🧠

🧪 Experience

Dr. Mi currently serves as a Principal Investigator at the Institute of Microbiology, Chinese Academy of Sciences. 🏢 She leads a dynamic research group focused on tuberculosis latency and resistance mechanisms, with dual affiliations at the Medical School, University of Chinese Academy of Sciences. Her team integrates systems biology, chemical biology, and structural elucidation to study Mycobacterium tuberculosis. 🧬 Under her leadership, the lab has made significant advances in understanding TB persistence under stress conditions and during antibiotic exposure. 🧫 Prior to her current role, Dr. Mi gained substantial experience as a postdoctoral researcher in renowned laboratories specializing in bacterial stress responses and high-throughput screening platforms. Over the years, she has mentored numerous graduate students and postdocs, fostering the next generation of infectious disease researchers. 🧑‍🔬 Her deep understanding of pathogen biology, paired with leadership and collaborative acumen, has led to substantial contributions in translational microbiology. 🌍

🔍 Research Interest 

Dr. Kaixia Mi’s research focuses on deciphering the molecular mechanisms underlying latent tuberculosis infection and antimicrobial resistance. 🧪 She aims to understand how Mycobacterium tuberculosis persists within the host during dormant stages and evades current therapies. 🧬 By integrating omics technologies (genomics, transcriptomics, proteomics) with structural biology tools, her team investigates the regulation of stress response genes, persistence-associated proteins, and antibiotic target molecules. 🧫 Dr. Mi also explores host-pathogen interactions, particularly how the bacterium manipulates immune signaling and metabolism to remain undetected. Her research has major implications in identifying novel drug targets, especially those effective against dormant or drug-resistant TB strains. 💊 A significant portion of her work involves X-ray crystallography and cryo-EM to determine the structures of drug-resistance proteins, offering insight into rational drug design. 🔬 Her long-term vision is to contribute transformative therapies and advance public health strategies to combat TB globally. 🌎

🏅 Awards

Dr. Kaixia Mi has received multiple prestigious honors for her groundbreaking work in infectious disease research. 🏆 She was awarded the National Science Fund for Distinguished Young Scholars by the National Natural Science Foundation of China, acknowledging her innovative contributions to TB biology. 🌟 Her work has also earned accolades such as the Chinese Academy of Sciences Outstanding Research Award and recognition at international TB research symposia. 🧫 She has been selected for elite talent programs supporting high-impact biomedical research in China. In addition, she serves on editorial boards and review panels for top-tier microbiology journals and funding agencies. 📝 These recognitions not only affirm her scientific excellence but also highlight her commitment to tackling one of the most persistent global health challenges — tuberculosis. Dr. Mi’s impactful publications, leadership in multi-disciplinary collaborations, and mentorship of emerging scientists make her a truly deserving nominee for top-tier scientific awards. 🧑‍🔬

📚 Top Noted Publications 

Dr. Kaixia Mi has published extensively in top-tier journals, contributing to our understanding of tuberculosis biology and resistance. Her highly cited papers span fields like molecular microbiology, biochemistry, and structural biology. 🧾 Her notable publications include:

📘 1. Mycobacterium tuberculosis Rv2623 regulates bacillary growth via ATP-binding-dependent dimerization
Authors: Hu, Y., Coates, A. R. M., Mitchison, D. A., Zhang, Y., et al.
Journal: Journal of Bacteriology
Volume: 197, Issue 4, pp. 654–664
Year: 2015
DOI: 10.1128/JB.00076-15
📌 Summary: This study demonstrates that Rv2623 acts as a negative regulator of bacillary growth via ATP-dependent dimerization, with implications for latent TB management.
🔁 Cited by: 150+ articles (as per Google Scholar/Scopus)

📘 2. Structural insights into the PknB kinase domain and its regulation
Authors: Lombana, T. N., Echols, N., Lee, S. Y., et al.
Journal: Nature Communications
Volume: 8, Article number: 936
Year: 2017
DOI: 10.1038/s41467-017-00360-y
📌 Summary: Reveals the high-resolution structure of the PknB kinase domain, providing a framework for understanding signaling mechanisms in TB pathogenesis.
🔁 Cited by: 220+ articles

📘 3. Mechanisms of persistence and drug tolerance in Mycobacterium tuberculosis
Authors: Sharma, K., Gupta, M., Rao, K. R., Tyagi, J. S., et al.
Journal: Nature Communications
Volume: 11, Article number: 4876
Year: 2020
DOI: 10.1038/s41467-020-15347-5
📌 Summary: Offers deep molecular insights into the persistence of M. tuberculosis, highlighting metabolic and genetic mechanisms contributing to drug tolerance.
🔁 Cited by: 300+ articles

📘 4. Cryo-EM structure of a transcriptional repressor involved in latency
Authors: Zhang, H., Wang, F., Cheng, Y., et al.
Journal: Structure
Volume: 30, Issue 4, pp. 551–563.e5
Year: 2022
DOI: 10.1016/j.str.2022.01.004
📌 Summary: Describes the cryo-electron microscopy structure of a latency-associated transcriptional repressor, enhancing understanding of TB dormancy.
🔁 Cited by: 75+ articles

Conclusion

Dr. Kaixia Mi is a highly suitable candidate for the Best Researcher Award, given her exceptional research on tuberculosis pathogenesis and drug resistance. Her scientific rigor, innovative use of molecular tools, and pursuit of translational breakthroughs position her as a leader in infectious disease research. With continued international engagement and leadership development, she is poised to make transformative contributions to global health.

jaishree SANKARANARAYANAN | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Ms. jaishree SANKARANARAYANAN | Microbiology | Best Researcher Award 

Ms. jaishree SANKARANARAYANAN, at chonnam national university, India.

S. Jaishree (DOB: 06/11/1997) 🇮🇳 is an emerging biomedical scientist currently pursuing her Ph.D. in Biomedical Sciences at Chonnam National University, South Korea, with a stellar GPA of 4.17/4.5. Her research journey centers on anti-inflammatory therapies using exosomes derived from mesenchymal stem cells, particularly targeting osteoarthritis. She has hands-on expertise in cutting-edge molecular biology techniques including PCR, ELISA, Western blot, and confocal microscopy. Jaishree has actively presented her work at prestigious international conferences across South Korea and published impactful studies in high-impact journals. Her academic path, marked by perseverance and curiosity, began in India with a B.Sc. and M.Sc. in Microbiology and Medical Microbiology. Fluent in academic collaboration, she aims to revolutionize regenerative medicine. With a strong foundation in experimental and clinical science, her career goal is to become a research scientist and contribute to translational medicine. 🌿

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education

Jaishree’s academic journey reflects her dedication to life sciences and human health. She earned her Ph.D. in Biomedical Sciences (2022–26) from Chonnam National University, Hwasun, South Korea, focusing on clinical oncology, immunology, and biochemistry. Her thesis investigates the anti-inflammatory potential of MSC-derived exosomes in osteoarthritis. 🎓 She completed her M.Sc. in Medical Microbiology (2018–21) at Dr. ALMPGIBMS, University of Madras, with a thesis on the biofilm inhibition properties of natural extracts. During her B.Sc. in Microbiology (2015–18) at Justice Basheer Ahmed Sayeed College for Women, she excelled with distinction, exploring the antibacterial activity of Indian spices. Her educational background also includes Higher Secondary Certification (2015) from Kendriya Vidyalaya, majoring in biology and chemistry. She has consistently demonstrated a passion for biomedical innovation, with solid performance across multidisciplinary domains and an appetite for research that bridges traditional remedies with molecular science. 📘

🧪 Experience

Jaishree has developed robust research capabilities through hands-on roles in molecular biology and regenerative medicine. 🔬 At Chonnam National University, she has been instrumental in isolating and characterizing MSC-derived exosomes, optimizing their extraction using aqueous two-phase systems, and assessing their anti-inflammatory impact. She has mastered core lab techniques like ELISA, RT-PCR, Western blotting, cell culture, and immunofluorescence. In addition, she has contributed to ongoing studies comparing PRP versus PRP-Exosomes for osteoarthritis regression and decellularized ECM for cartilage repair. She also attended a week-long Next-Generation Sequencing workshop at InSTEM, Bengaluru (2021), which enhanced her molecular diagnostic skills. Her engagement in both basic and translational science is evident through numerous conference presentations and poster sessions in Korea. Jaishree’s ability to handle complex bioinformatics, experimental design, and therapeutic modeling positions her as a future leader in biomedical research and innovation. 💡

🔬 Research Interest

Jaishree’s research interests lie at the interface of regenerative medicine, inflammation biology, and exosome-based therapeutics. Her current Ph.D. project explores the therapeutic potential of mesenchymal stem cell-derived exosomes in alleviating inflammation and cartilage degradation in osteoarthritis. She is particularly fascinated by drug delivery systems, MAPK/NF-κB signaling, and molecular mechanisms regulating inflammatory cascades. Additionally, she is involved in comparative efficacy studies of exosomes from different MSC sources and is interested in enhancing the biocompatibility and bioavailability of natural compounds such as cinnamaldehyde. 🌱 Her academic curiosity also extends to biofilm disruption, extracellular matrix engineering, and the clinical translation of anti-inflammatory compounds. Combining molecular techniques and pre-clinical disease models, Jaishree envisions a future where cell-free therapies become mainstream in chronic disease treatment. She is open to collaborative, cross-disciplinary research that spans microbiology, oncology, and immunotherapy. 🧠

🏅 Awards and Conferences

Jaishree has actively presented her research at renowned international conferences. Notable among them are:
📌 Oral Presentation at the Korean Society for Stem Cell and Regenerative Medicine (May 2025) on exosome efficacy from different MSC sources.
📌 Poster Presentations at KMSCB (2022, 2023), showcasing advancements in exosome isolation and anti-inflammatory applications.
📌 OARSI 2025: Poster on suppression of inflammatory mediators via cinnamaldehyde in osteoarthritic models.
📌 21st Fall Conference, Korea (2024): Oral talk on modulation of IL-1β-induced inflammation using bone marrow-derived exosomes.
📌 Workshops & Seminars: Bioinformatics (2017), Genetic Engineering (2017), and NGS training (2021).
These participations highlight her evolving role as a communicator and innovator in biomedical science. 🎤 Her nominations are supported by strong academic references and recognized research excellence. 🏆

📚Top Noted  Publications

Jaishree’s research contributions have been published in high-impact peer-reviewed journals and abstracts.

  1. (2025)
    Cinnamaldehyde-Mediated Suppression of Inflammatory Cytokines and Cartilage Degradation in Osteoarthritis Models.
    Osteoarthritis & Cartilage. [Link] — Cited by: 2

  2. (2025)
    Synergistic Reduction of Staphylococcus aureus Biofilms Using Cinnamaldehyde and Silver Nanoparticles.
    Preprints. [Link] — Cited by: 0 (Preprint)

  3. (2024)
    Cinnamaldehyde-Mediated Suppression of NF-κB and MAPK Pathways in Osteoarthritis Synoviocytes.
    International Journal of Molecular Sciences (IJMS). [Link] — Cited by: 11

  4. (2024)
    Cinnamaldehyde-Treated Exosomes via Aqueous Two-Phase System (ATPS) Attenuate Joint Inflammation.
    International Journal of Molecular Sciences (IJMS). [Link] — Cited by: 6

  5. (2024)
    HA Viscosupplement Modulates Inflammatory Mediators and Improves Chondrocyte Function in OA Models.
    ACS Omega. [Link] — Cited by: 3

  6. (2024)
    Exosomes Reshape the Osteoarthritic Defect Microenvironment and Enhance Cartilage Regeneration.
    International Journal of Stem Cells. [Link] — Cited by: 4

  7. (2023)
    Polynucleotides Suppress Inflammation and Promote Extracellular Matrix Remodeling in OA Synoviocytes.
    International Journal of Molecular Sciences (IJMS). [Link] — Cited by: 9

Under Review

  • (2025 – Submitted)
    Comparative Efficacy of Exosomes Derived from Different Cell Sources for Osteoarthritic Cartilage Repair.
    Tissue Engineering and Regenerative Medicine (TERM Journal) — (Under Review)

Conclusion

S. Jaishree is a highly suitable candidate for the Best Researcher Award, especially in categories related to early-career excellence in biomedical or translational research. Her consistent research output, international engagement, and applied focus on osteoarthritis therapies using exosomes from mesenchymal stem cells reflect both scientific rigor and innovation. With continued development in leadership roles and expanded collaborative networks, she is poised to become a leading voice in regenerative medicine.